Ophthalmology And Visual Sciences

Elliott H. Sohn, MD


Assistant Professor of Ophthalmology and Visual Sciences

Contact Information

Primary Office: 11196 H PFP
Iowa City, IA 52242
Primary Office Phone: 319-356-8350

Email: elliott-sohn@uiowa.edu


BA, Chemistry, Williams College
MD, University of Washington School of Medicine

Internship, Internal Medicine, University of Washington
Residency, Ophthalmology, University of Washington
Fellowship, Medical Retina, Moorfields Eye Hospital
Fellowship, Vitreoretinal Surgery, Doheney Eye Institute/USC

Licensure and Certifications

ABO Certification, American Board of Ophthalmology
NBME Diplomate, National Board of Medical Examiners

Center, Program and Institute Affiliations

Carver Family Center for Macular Degeneration
Stephen A. Wynn Institute for Vision Research

Selected Publications

Show All

Russell S, Sohn E, Boldt H, Folk J, Tarantola R, Kay C, Mahajan V.  Elimination of infusion bubbles and uncontrolled reflux in the Alcon Constellation Vitrectomy Vision System.  Retina.  2013 April. 33(4):803-806.

Cunningham M, Tarantola R, Folk J, Sohn E, Boldt H, Graff J, Elkins K, Russell S, Mahajan V.  Proliferative vitreoretinopathy may be a risk factor in combined macular hole retinal detachment cases.  Retina.  2013 March. 33(3):579-585.

Sohn E, Mullins R, Stone E.  Macular dystrophies.  Saunders/Elsevier.  2013. 

Chen X, Zhang L, Sohn E, Lee K, Niemeijer M, Chen J, Sonka M, Abramoff M.  Quantification of external limiting membrane disruption caused by diabetic macular edema from SD-OCT.  Invest Ophthalmol Vis Sci.  2012 December 7. 53(13):8042-8048.

Sohn E, Wang R, Read R, Roufas A, Teo L, Moorthy R, Albini T, Vasconcelos-Santos D, Dustin L, Chee S, Zamir E, McCluskey P, Smith R, Rao N.  Regional corticosteroids for scleritis: Reply.  Ophthalmology.  2012 October. 119(10):2199-2200.

Sohn E, He S, Kim L, Salehi-Had H, Javaheri M, Spee C, Dustin L, Hinton D, Eliott D.  Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment. Report No. 1.  Arch Ophthalmol.  2012 September 1. 130(9):1127-1134.

Davis A, Folk J, Russell S, Sohn E, Boldt H, Stone E, Mahajan V.  Intravitreal bevacizumab for peripapillary choroidal neovascular membranes.  Arch Ophthalmol.  2012 August 1. 130(8):1073-1075.

Kay C, Abramoff M, Mullins R, Kinnick T, Lee K, Eyestone M, Chung M, Sohn E, Stone E.  Three dimensional distribution of the vitelliform lesion, photoreceptors, and retinal pigment epithelium in the macula of patients with Best vitelliform macular dystrophy.  Arch Ophthalmol.  2012 March. 103(3):357-364.

Sohn E, Patel P, Maclaren R, Adatia F, Pal B, Webster A, Tufail A.  Responsiveness of choroidal neovascular membranes in patients with R345W mutation in fibulin-3 (Doyne honeycomb retinal dystrophy) to anti-vascular endothelial growth factor therapy.  Arch Ophthalmol.  2011 December. 129(12):1626-1628.

Sohn E, Wang R, Read R, Roufas A, Teo L, Moorthy R, Albini T, Vasconcelos-Santos D, Dustin L, Zamir E, Chee S, McCluskey P, Smith R, Rao N.  Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis.  Ophthalmology.  2011 October. 118(10):1932-1937.

Date Last Modified: 10/13/2014 - 13:16:59